Introduction
reversed vein grafting. [5] [6] [7] [8] [9] In the Scandinavian countries the reversed vein bypass has been almost abandoned Widespread experience has proven the autologous in favour of the in situ technique and PTA. 10 However, several randomised studies have failed to show a saphenous vein to be the best graft material for infrainguinal bypass. Whether the vein should be reversed significant difference between the two techniques. [11] [12] [13] [14] A problem is that these studies were rather small and, or left in situ is a matter of debate. The reversed method has become well established in the last 50 hence, do not allow robust conclusions. We therefore analysed the patency data on reversed and in situ years as a procedure with good durable results. Many still consider this time-honoured technique the ''gold-bypasses collected within the Dutch BOA Study, a large randomised clinical trial, comparing the efficacy standard'' for infrainguinal arterial reconstruction. patients who were enrolled in the study gave informed Results written consent. Between April 1995 and March 1998 Demographic and clinical characteristics of the patients a total of 2645 patients were randomised. For each in both groups, subdivided according to femoropatient vascular history, risk factors, clinical category popliteal and femorocrural bypasses are shown in of limb ischaemia, medication and operation details Table 1 . The two groups requiring femoropopliteal were recorded. All patients with an in situ saphenous bypass were similar with regard to most baseline vein graft (n=500) and all patients with a reversed characteristics except for the site of the distal anagreater saphenous vein graft (n=955) were selected stomosis (more below-knee in situ grafts) and the for the present study. The operative technique to be angiographic run-off (worse in the in situ group). The used within the trial was left to the discretion of the two groups requiring femorocrural bypass were also surgeon. In 15 of the 77 participating hospitals the in similar; however, there were more previous vascular situ graft was predominantly used. In 24 hospitals interventions in the reversed group and more patients only the reversed method was used for infrainguinal within this group were operated on for critical ischbypass. Vascular surgeons at 20 of the 53 participating aemia than in the group with in situ grafts. There hospitals who included patients with femorocrural was no difference in mean hospital stay between the bypasses, preferred the in situ method for this proreversed and the in situ group: 13.9 versus 13.4 days cedure.
for femoropopliteal bypass procedures, and 20.6 verPatients were seen 3 and 6 months postoperatively sus 20.3 days for femorocrural bypasses. The allocated and every 6 months thereafter. The primary endpoint postoperative antithrombotic treatment (oral antiwas bypass occlusion, which was mostly confirmed coagulants of aspirin) was well balanced between the by duplex scanning or angiography. Adverse patient groups. The mean follow-up of all included patients outcomes including death, major amputation of the was 12.6 months (reversed: 13. Hazard ratios (HRs) were calculated for all baseline Standards. Primary patency was defined as un-characteristics. Variables predictive for occlusion of interrupted patency without any procedures per-femoropopliteal bypasses were female gender: HR 1.54 formed on the graft or on its anastomoses. If minor (95% CI 1.13-2.12); poor angiographic run-off: HR graft revisions, such as ligation of arteriovenous fistula, 1.60 (95% CI 1.14-2.24) and clinical signs of critical incision of residual valve leaflets, or PTA of graft ischaemia: HR 1.70 (95% CI 1. 24-2.33) . No predictive stenosis or adjacent artery, were necessary to avoid variables were found for occlusion of femorocrural graft occlusion, the graft was classified under assisted bypasses. primary patency. If graft patency was restored after occlusion by thrombectomy or thrombolysis and eventually completed with PTA or a minor graft rePrimary patency placement the graft was classified under secondary patency. Patency rates for in situ and reversed grafts In femoropopliteal bypass the 2-year primary patency and limb salvage rates were compared with the log rate was 67% for in situ and 74% for reversed veins, rank test (SPSS Inc., Chicago, IL, statistical package). p=0.02 (Figure 1 ). The corresponding HR for loss of The risk of bypass occlusion, the need for graft revision, primary patency (occlusion or need for secondary and the risk for major amputation were also compared intervention) was 1.51 (95% CI 1.15-1.98). In femby means of hazard ratios with corresponding 95% orocrural bypass the 2-year primary cumulative patconfidence intervals. Because the study design did not ency was for in situ (52%) and for reversed (63%), p= use random assignment according to grafting tech-0.04. The corresponding HR for loss of primary patency nique, we used multivariate Cox regression analysis was 1.50 (95% CI 1.03-2.18). Adjustment for baseline to adjust for possible incomparabilities between the variables did not change the significant greater risk of groups. We analysed the data separately for fem-occlusion or need for secondary intervention in the in situ femoropopliteal and femorocrural bypass group. oropopliteal and femorocrural bypasses. Assisted primary patency 2). In femorocrural bypass the 2-year assisted primary cumulative patency was 69% for in situ and 70% for In femoropopliteal bypasses the 2-year assisted prim-reversed veins, p=0.68. The corresponding HR for occlusion was 1.13 (95% CI 0.73-1.75). Again adary patency rate was 82% for in situ and 82% for reversed, p=0.14 ( Fig. 2) . The corresponding HR for justment for variables that were unequally distributed (previous vascular intervention and preoperative clinloss of assisted primary patency (occlusion) was 1.51 (95% CI 0.90-1.77). Adjustment for the identified risk ical stage) only had a marginal influence on the results (Table 2) . factors did not change these results significantly (Table 
Secondary patency Graft revision
The 2-year secondary patency in femoropopliteal by-In the total group of patients, 231 secondary interventions were necessary to maintain integrity or pass was 85% for in situ and 84% for reversed veins, p=0.59 (Fig. 3) . In femorocrural bypass the 2-year patency of the graft: 124 in the group of patients with an in situ graft (n=500) and 107 in the group with a cumulative secondary patency was 74% for in situ and 71% for reversed veins, p=0.72. The HR for occlusion reversed graft (n=955). The numbers are shown in Table 3 , stratified for femoropopliteal bypass and femwas for femoropopliteal bypasses 1.11 (CI 95% 0.76-1.60 and for femorocrural bypasses 0.91 (CI 95% 0.58-orocrural bypass. Significantly more secondary interventions were necessary in the in situ group, especially 1.46). After adjustment for relevant baseline variables these results were essentially the same.
in long (femorocrural) bypasses. Three interventions were necessary for graft infection (one in situ and two 1.41 (95% CI 0.71-2.79) for femoropopliteal bypasses and 1.20 (95% CI 0.65-2.25) for femorocrural bypasses. reversed veins).
In the ten patients with a reversed graft with a pedal anastomosis no graft occlusion occurred and no major amputations were necessary. In the group of twentyLimb salvage four patients with an in situ graft with a pedal anastomosis six occlusions occurred and five major amFor analysis of limb salvage, only patients with critical putations were needed. ischaemia at baseline were selected. The 2-year limb salvage rate for patients with a femoropopliteal bypass (n=496) was 89% for in situ and 92% for reversed Discussion veins, p=0.31 (Fig. 4) . The 2-year limb salvage rate for patients with a femorocrural bypass (n=312) was The results of this study indicate that claims for superiority of in situ grafts over reversed grafts in fem-82% for in situ and 85% for reversed veins, p=0.31. The HR for major amputation (in situ vs. reversed) is oropopliteal and femorocrural bypass surgery are unjustified. In terms of assisted primary patency, has improved the outcome substantially, hence comparison with historic controls is biased. In other nonsecondary patency and limb salvage, we observed no statistically significant differences. The corresponding randomised series a clear selection bias was introduced because comparison was made with a second-choice risk for graft occlusion was no different for either technique. The primary patency is both dependent on reversed graft (for example spliced or ectopic veins) which was only used if in situ grafting was not feasthe occlusion rate and the occurrence of graft problems that need minor graft revisions to avoid graft occlusion. ible. 21 In the current study only reversed greater saphenous vein grafts were selected for comparison with The present study showed that the primary patency in femoropopliteal and femorocrural bypass surgery in situ grafts, often as first choice.
Besides these favourable comparisons with historic is in favour of reversed bypass grafting. The risk of occlusion or secondary intervention is greater for the controls or second choice grafts a few theoretical advantages of the in situ graft have been suggested. The in situ bypass. The reason for this difference is the proportion of secondary interventions needed after in vein utilisation rate using the in situ technique might be higher because smaller calibre veins can be used.
5 situ operation to maintain integrity and patency of the graft.
In two of the randomised trials 13, 14 and several studies about the influence of graft diameter on graft patWe compared two parallel study groups in whom the bypass technique was non-randomly allocated. ency [22] [23] [24] smaller veins performed very badly, independently of which kind of grafting was applied. Hence the two groups differed to some extent with regard to the risk of graft occlusion. However, if we Thus, it may be technically possible to utilise smaller veins by the in situ technique because of a better adjusted the crude hazard ratios for the variables predictive for occlusion, we found essentially the same match to the recipient artery, but the results make the employment of such small veins questionable for either results. We therefore conclude that baseline differences did not play a major role in our study. Seventy-seven technique. Moreover, utilisation rates are only valid if all patients who require infrainguinal bypass surgery hospitals from all over The Netherlands participated in this investigation; in 30% of hospitals, only reversed are investigated, not just those with an intact ipsilateral greater saphenous vein. A major disadvantage of the grafts were used, whereas in 50% in situ grafts were used, if a femorocrural bypass was needed. This in situ technique is that use of an ipsilateral saphenous vein is mandatory. Leather et al. reported, on the heterogeneity reflects current surgical practice in The Netherlands. The findings of the present study are to biggest series of in situ bypass operations, that about 30% of patients who needed a venous bypass were a large extent in accordance with the results of four randomised trials [11] [12] [13] [14] and several non-randomised operated on with the (partially) reversed method because a complete in situ bypass procedure was imcomparative studies. [16] [17] [18] Some authors who have claimed superiority for the in situ graft compared the possible. 6 In one of the randomised studies 37% of the candidates for randomisation were excluded because patency rates of this graft type with a non-contemporaneous series of the reversed bypass op-it was impossible to perform an in situ graft; 30% of these patients underwent a reversed vein bypass. 11 In erations. 19, 20 The evolution of the reversed technique our study we did not obtain data that allowed analysis ipsilateral greater saphenous vein is missing. If the ipsilateral greater saphenous vein is available, the of vein utilisation rates for either the reversed or in present study has shown that neither technique gives situ bypass technique.
significantly better assisted primary patency, secIn the in situ technique preservation of the endoondary patency rates, or limb salvage. Relatively more thelial lining by keeping the vasa vasorum intact secondary interventions are needed to maintain the should lead to a less thrombogenic flow surface and integrity and patency of the in situ graft, especially improved fibrinolytic activity. There is little exafter femorocrural bypass surgery. A large-scale ranperimental evidence to support this theory. 25, 26 The domised study with special emphasis on graft surextent of de-endothelialisation caused by valve stripveillance and a strict strategy for treating graft stenoses pers is much higher than previously believed. [26] [27] [28] [29] investigating 128 in situ grafts and 172 non-in situ
